PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation
Conclusion: Our findings identify PTC-209 as a promising anticancer agent for the treatment of solid tumors either alone and/or in combination with the standard cytotoxic drugs cisplatin and camptothecin and the natural product Frondoside-A.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Drugs & Pharmacology | Eloxatin | Immunotherapy | Lung Cancer | Toxicology